WALGREENS BOOTS ALLIANCE INC (WBA)

US9314271084 - Common Stock

17.7  +0.1 (+0.57%)

After market: 17.75 +0.05 (+0.28%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

WALGREENS BOOTS ALLIANCE INC

NASDAQ:WBA (4/26/2024, 7:23:53 PM)

After market: 17.75 +0.05 (+0.28%)

17.7

+0.1 (+0.57%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorConsumer Staples
GICS IndustryConsumer Staples Distribution & Retail
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap15.27B
Shares
PE5.01
Fwd PE5.68
Dividend Yield5.68%
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

WBA Daily chart

Company Profile

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. The company is headquartered in Deerfield, Illinois and currently employs 206,000 full-time employees. The company went IPO on 2014-12-31. Its segments include U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment includes the Walgreens business, which includes the operations of retail drug stores, health and wellness services, and specialty and home delivery pharmacy services, and its equity method investment in Cencora, Inc. The International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution business in Germany. The pharmacy-led health and beauty retail businesses include Boots branded stores in the United Kingdom, the Republic of Ireland and Thailand, the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omni-channel experience across the care journey.

Company Info

WALGREENS BOOTS ALLIANCE INC

108 Wilmot Rd

Deerfield ILLINOIS 60015

P: 18473152500

CEO: Rosalind Brewer

Employees: 206000

Website: https://www.walgreensbootsalliance.com/

WBA News

News Image2 days ago - CNBCCramer's week ahead: Fed meeting and earnings from Apple, Amazon, Eli Lilly

CNBC's Jim Cramer on Friday walked investors through next week on Wall Street.

News Image3 days ago - The Business JournalsWalgreens to open cell and gene therapy pharmacy center in Pittsburgh
News Image4 days ago - Walgreens Boots AllianceWalgreens Boots Alliance Declares Quarterly Dividend
News Image4 days ago - CNBCWalgreens to help bring cell and gene therapies to patients as it expands specialty pharmacy services

Among the company's investments to "transform" its specialty pharmacy services is the opening of a new facility dedicated to cell and gene therapy services.

News Image4 days ago - BloombergWalgreens Is Opening a New Pharmacy For Cell and Gene Therapies

Walgreens Boots Alliance Inc. is opening a new center dedicated to bringing emerging cell and gene therapies to patients with complex, chronic conditions like cancer, cystic fibrosis and Crohn’s disease.

News Image4 days ago - WalgreensWalgreens Launches Gene and Cell Services as Part of Newly Integrated Walgreens Specialty Pharmacy Business

WBA Twits

Here you can normally see the latest stock twits on WBA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example